TM
TMDX icon

Torren Management’s Transmedics TMDX Stock Holding History

Torren Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11
Closed -$1.09K – 975
2026
Q1 		$1.09K Hold
11
– – ﹤0.01% 716
2025
Q4 		$1.34K Buy
+11
New +$1.38K ﹤0.01% 1143

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
ZCI
Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Torren Management's TMDX Position: Q2 2026 in Review

Torren Management sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 11 shares — an estimated $1.09K sold.

Torren Management first reported a position in TMDX in Q4 2025 and held it in 2 quarters. The position peaked at $1.34K in Q4 2025. 166 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Torren Management reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
  • Torren Management sold 11 Transmedics shares in Q2 2026, an estimated $1.09K.
  • Torren Management first reported a position in Transmedics in Q4 2025 and held it in 2 quarters.
  • Torren Management's Transmedics position peaked at $1.34K in Q4 2025.
  • 166 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Torren Management's 13F filing for Q2 2026, filed 10 Jul 2026.